Beta-1 adrenergic agonist
This page covers all Beta-1 adrenergic agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-1 adrenergic receptor.
Targets
Marketed (1)
- Post-CPB Drug: Dobutamine Hydrochloride · University Health Network, Toronto · Cardiovascular
Dobutamine is a beta-1 adrenergic agonist that increases cardiac contractility and heart rate to improve cardiac output in patients with low cardiac function.
Phase 3 pipeline (1)
- DOBUTamine Injectable Solution · The Young Investigator Group of Cardiovascular Research · Cardiovascular
Dobutamine is a beta-1 adrenergic agonist that increases cardiac contractility and heart rate to improve cardiac output.